These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 38805506)

  • 1. Deletion of Hsd11b1 suppresses caloric restriction-induced bone marrow adiposity in male but not female mice.
    Lovdel A; Suchacki KJ; Roberts F; Sulston RJ; Wallace RJ; Thomas BJ; Bell RMB; Pruñonosa Cervera I; Macpherson GJ; Morton NM; Homer NZM; Chapman KE; Cawthorn WP
    J Endocrinol; 2024 Aug; 262(2):. PubMed ID: 38805506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficiency of glucocorticoid receptor in bone marrow adipocytes has mild effects on bone and hematopoiesis but does not influence expansion of marrow adiposity with caloric restriction.
    Schill RL; Visser J; Ashby ML; Li Z; Lewis KT; Morales-Hernandez A; Hoose KS; Maung JN; Uranga RM; Hariri H; Hermsmeyer IDK; Mori H; MacDougald OA
    Front Endocrinol (Lausanne); 2024; 15():1397081. PubMed ID: 38887268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 11-Dehydrocorticosterone causes metabolic syndrome, which is prevented when 11β-HSD1 is knocked out in livers of male mice.
    Harno E; Cottrell EC; Keevil BG; DeSchoolmeester J; Bohlooly-Y M; Andersén H; Turnbull AV; Leighton B; White A
    Endocrinology; 2013 Oct; 154(10):3599-609. PubMed ID: 23832962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-specific glucocorticoid reactivating enzyme, 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)--a promising drug target for the treatment of metabolic syndrome.
    Masuzaki H; Flier JS
    Curr Drug Targets Immune Endocr Metabol Disord; 2003 Dec; 3(4):255-62. PubMed ID: 14683456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extra-adrenal regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1: physiological regulator and pharmacological target for energy partitioning.
    Walker BR
    Proc Nutr Soc; 2007 Feb; 66(1):1-8. PubMed ID: 17343766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary manipulation reveals an unexpected inverse relationship between fat mass and adipose 11β-hydroxysteroid dehydrogenase type 1.
    Man TY; Michailidou Z; Gokcel A; Ramage L; Chapman KE; Kenyon CJ; Seckl JR; Morton NM
    Am J Physiol Endocrinol Metab; 2011 Jun; 300(6):E1076-84. PubMed ID: 21406612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 11β-HSD1 is the major regulator of the tissue-specific effects of circulating glucocorticoid excess.
    Morgan SA; McCabe EL; Gathercole LL; Hassan-Smith ZK; Larner DP; Bujalska IJ; Stewart PM; Tomlinson JW; Lavery GG
    Proc Natl Acad Sci U S A; 2014 Jun; 111(24):E2482-91. PubMed ID: 24889609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 as a promising therapeutic target.
    Wamil M; Seckl JR
    Drug Discov Today; 2007 Jul; 12(13-14):504-20. PubMed ID: 17631244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 11β-hydroxysteroid dehydrogenase-1 deficiency alters brain energy metabolism in acute systemic inflammation.
    Verma M; Kipari TMJ; Zhang Z; Man TY; Forster T; Homer NZM; Seckl JR; Holmes MC; Chapman KE
    Brain Behav Immun; 2018 Mar; 69():223-234. PubMed ID: 29162555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 11β-hydroxysteroid dehydrogenase type 1 deficiency in bone marrow-derived cells reduces atherosclerosis.
    Kipari T; Hadoke PW; Iqbal J; Man TY; Miller E; Coutinho AE; Zhang Z; Sullivan KM; Mitic T; Livingstone DE; Schrecker C; Samuel K; White CI; Bouhlel MA; Chinetti-Gbaguidi G; Staels B; Andrew R; Walker BR; Savill JS; Chapman KE; Seckl JR
    FASEB J; 2013 Apr; 27(4):1519-31. PubMed ID: 23303209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 11β-HSD1 suppresses cardiac fibroblast CXCL2, CXCL5 and neutrophil recruitment to the heart post MI.
    Mylonas KJ; Turner NA; Bageghni SA; Kenyon CJ; White CI; McGregor K; Kimmitt RA; Sulston R; Kelly V; Walker BR; Porter KE; Chapman KE; Gray GA
    J Endocrinol; 2017 Jun; 233(3):315-327. PubMed ID: 28522730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver-selective transgene rescue of hypothalamic-pituitary-adrenal axis dysfunction in 11beta-hydroxysteroid dehydrogenase type 1-deficient mice.
    Paterson JM; Holmes MC; Kenyon CJ; Carter R; Mullins JJ; Seckl JR
    Endocrinology; 2007 Mar; 148(3):961-6. PubMed ID: 17170103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of 11β-hydroxysteroid dehydrogenase type 1 following caloric restriction and re-feeding is species dependent.
    Loerz C; Staab-Weijnitz C; Huebbe P; Giller K; Metges C; Rimbach G; Maser E
    Chem Biol Interact; 2017 Oct; 276():95-104. PubMed ID: 28254522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of endogenous glucocorticoids and their intravascular metabolism by 11β-HSDs to postangioplasty neointimal proliferation in mice.
    Iqbal J; Macdonald LJ; Low L; Seckl JR; Yau CW; Walker BR; Hadoke PW
    Endocrinology; 2012 Dec; 153(12):5896-905. PubMed ID: 23125311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoids and 11beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome.
    Stimson RH; Walker BR
    Minerva Endocrinol; 2007 Sep; 32(3):141-59. PubMed ID: 17912154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 11β-Hydroxysteroid dehydrogenase type 1 shRNA ameliorates glucocorticoid-induced insulin resistance and lipolysis in mouse abdominal adipose tissue.
    Wang Y; Yan C; Liu L; Wang W; Du H; Fan W; Lutfy K; Jiang M; Friedman TC; Liu Y
    Am J Physiol Endocrinol Metab; 2015 Jan; 308(1):E84-95. PubMed ID: 25389364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 11β-HSD1 contributes to age-related metabolic decline in male mice.
    Morgan SA; Gathercole LL; Hassan-Smith ZK; Tomlinson J; Stewart PM; Lavery GG
    J Endocrinol; 2022 Dec; 255(3):117-129. PubMed ID: 36205523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoid excess alters metabolic rate and substrate utilisation via 11β-HSD1.
    Heaselgrave SR; Heising S; Morgan SA; Carthwright DM; Sagmeister M; Hardy RS; Doig CL; Morton N; Tsintzas K; Lavery GG
    J Endocrinol; 2024 Nov; 263(2):. PubMed ID: 39302000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoid regulation of the promoter of 11beta-hydroxysteroid dehydrogenase type 1 is indirect and requires CCAAT/enhancer-binding protein-beta.
    Sai S; Esteves CL; Kelly V; Michailidou Z; Anderson K; Coll AP; Nakagawa Y; Ohzeki T; Seckl JR; Chapman KE
    Mol Endocrinol; 2008 Sep; 22(9):2049-60. PubMed ID: 18617597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting osteoblastic 11β-HSD1 to combat high-fat diet-induced bone loss and obesity.
    Zhong C; Li N; Wang S; Li D; Yang Z; Du L; Huang G; Li H; Yeung WS; He S; Ma S; Wang Z; Jiang H; Zhang H; Li Z; Wen X; Xue S; Tao X; Li H; Xie D; Zhang Y; Chen Z; Wang J; Yan J; Liang Z; Zhang Z; Zhong Z; Wu Z; Wan C; Liang C; Wang L; Yu S; Ma Y; Yu Y; Li F; Chen Y; Zhang B; Lyu A; Ren F; Zhou H; Liu J; Zhang G
    Nat Commun; 2024 Oct; 15(1):8588. PubMed ID: 39362888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.